{"schema_version":"1","generated_at":"2026-10-29T20:31:41.068Z","data_as_of":"2026-10-24","url":"https://www.findmykol.com/kol/leland-metheny","json_url":"https://www.findmykol.com/kol/leland-metheny/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"leland-metheny","name":"Leland Metheny","credential":"MD","title":"Assistant Professor, University Hospitals","specialty":"Hematology","specialty_raw":"Hematology","therapeutic_area":"Myeloma","therapeutic_areas":["Myeloma","Leukemia"],"institution":"University Hospitals","institution_url":"https://www.findmykol.com/institution/university-hospitals","city":"Cleveland","state":"OH","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1336303817","orcid":"0000-0002-1980-9999","openalex":"A5039525847"},"summary":"Leland Metheny is Assistant Professor, University Hospitals at University Hospitals. OpenAlex indexes 173 publications with 1,694 citations (h-index 20); ClinicalTrials.gov lists 10 registered studies with this person as an investigator.","overview":{"text":"Leland Metheny, M.D., is Assistant Professor, University Hospitals. The public record shows 173 publications with 1,694 citations (h-index 20), centered on Hematopoietic Stem Cell Transplantation, Multiple Myeloma Research and Treatments, CAR-T cell therapy research. It also documents an investigator role on 10 registered clinical trials, industry payments reported by 10 companies, 1 NIH-funded awards (2021–2024).","bullets":["Most recent indexed publication: 2025 · Bone marrow transplantation","Top research focus: Hematopoietic Stem Cell Transplantation","10 registered trials on ClinicalTrials.gov","Open Payments reporting from 10 companies"],"generated_at":"2026-10-28"},"focus":{"indications":[{"label":"Leukemia (AML/ALL/CML/CLL)","therapeutic_area":"Oncology","trials":6,"topics":1,"strength":19},{"label":"MDS / MPN","therapeutic_area":"Oncology","trials":4,"topics":0,"strength":12},{"label":"Leukemia, Myeloid, Acute","therapeutic_area":"Oncology","trials":3,"topics":0,"strength":9},{"label":"Leukemia, Lymphoid","therapeutic_area":"Oncology","trials":3,"topics":0,"strength":9},{"label":"Lymphoma","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Recurrence","therapeutic_area":"Epidemiology","trials":2,"topics":0,"strength":6},{"label":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Hodgkin Disease","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Multiple Myeloma","therapeutic_area":"Oncology","trials":1,"topics":1,"strength":4},{"label":"Lymphoma, Non-Hodgkin","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Leukemia, Lymphocytic, Chronic, B-Cell","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Primary Myelofibrosis","therapeutic_area":"Hematology","trials":1,"topics":0,"strength":3},{"label":"Neuro-Oncology / Glioma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Sarcoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Gliosarcoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Coma","therapeutic_area":"Neurology","trials":1,"topics":0,"strength":3},{"label":"Lymphoproliferative Disorders","therapeutic_area":"Hematology","trials":1,"topics":0,"strength":3}],"research_topics":["Hematopoietic Stem Cell Transplantation","Multiple Myeloma Research and Treatments","CAR-T cell therapy research","Mesenchymal stem cell research","Acute Myeloid Leukemia Research"],"drugs_studied":{"total":12,"shown":3,"withheld":9,"rows":[{"name":"Besponsa","generic":"Inotuzumab ozogamicin","trials":0,"payments":1,"publications":2,"mentions":3},{"name":"Jakafi","generic":"Ruxolitinib","trials":0,"payments":68,"publications":0,"mentions":68},{"name":"Inqovi","generic":"Cedazuridine / decitabine","trials":0,"payments":15,"publications":0,"mentions":15}]},"works_with":{"total":13,"shown":3,"withheld":10,"rows":[{"name":"Incyte Corporation","trials":0,"payments":69,"mentions":69},{"name":"Taiho Oncology, Inc.","trials":0,"payments":15,"mentions":15},{"name":"National Marrow Donor Program","trials":0,"payments":11,"mentions":11}]}},"scholarship":{"works_count":173,"cited_by_count":1694,"h_index":20,"i10_index":30,"pubmed_count":11,"latest_activity_year":2025,"source":"works"},"trials":{"count":10,"shown":3,"withheld":7,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT06904482","title":"Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood","phase":"PHASE2","status":"RECRUITING","role":"Investigator","sponsor":"Case Comprehensive Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT06904482","trial_url":"https://www.findmykol.com/trial/NCT06904482"},{"nct":"NCT06680661","title":"ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis","phase":"PHASE2","status":"RECRUITING","role":"Investigator","sponsor":"Leland Metheny","source_url":"https://clinicaltrials.gov/study/NCT06680661","trial_url":"https://www.findmykol.com/trial/NCT06680661"},{"nct":"NCT05546723","title":"LMY-920 for Treatment of Relapsed or Refractory Myeloma","phase":"PHASE1","status":"RECRUITING","role":"Investigator","sponsor":"Luminary Therapeutics","source_url":"https://clinicaltrials.gov/study/NCT05546723","trial_url":"https://www.findmykol.com/trial/NCT05546723"}],"source":"trials"},"payments":{"company_count":10,"program_years":{"first":2021,"last":2025},"rows_total":17,"shown":3,"withheld":14,"rows":[{"payer":"Incyte Corporation","program_year":2025,"amount_usd":124.82,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1336303817"},{"payer":"Novartis Pharmaceuticals Corporation","program_year":2025,"amount_usd":69.09,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1336303817"},{"payer":"Janssen Biotech, Inc.","program_year":2025,"amount_usd":22.48,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1336303817"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1336303817","source":"payments"},"prescribing":{"data_year":2024,"areas_total":8,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":56.4,"classes_total":4,"classes":[{"class":"Kinase inhibitor","setting":"prescribed","share_pct":33.1,"drugs":[{"name":"Imbruvica","share_pct":48.9},{"name":"Calquence","share_pct":42.5},{"name":"Jakafi","share_pct":8.6}],"max_beneficiaries":null},{"class":"Antimetabolite","setting":"prescribed","share_pct":10.5,"drugs":[{"name":"Hydroxyurea","share_pct":100}],"max_beneficiaries":14}]},{"area":"Dermatology","share_pct":13.7,"classes_total":1,"classes":[{"class":"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor","setting":"prescribed","share_pct":13.7,"drugs":[{"name":"Acyclovir","share_pct":100}],"max_beneficiaries":29}]},{"area":"Nervous system","share_pct":8.5,"classes_total":3,"classes":[{"class":"Phenothiazine","setting":"prescribed","share_pct":3.9,"drugs":[{"name":"Prochlorperazine Maleate","share_pct":100}],"max_beneficiaries":15},{"class":"Gabapentinoids","setting":"prescribed","share_pct":2.5,"drugs":[{"name":"Gabapentin","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"funding":{"award_count":1,"fiscal_years":{"first":2021,"last":2024},"rows_total":4,"shown":3,"withheld":1,"rows":[{"project":"P30CA043703","title":"Procotol Review and Monitoring System","fiscal_year":2024,"amount_usd":203535,"organization":"CASE WESTERN RESERVE UNIVERSITY","source_url":"https://reporter.nih.gov/quickSearch/P30CA043703"},{"project":"P30CA043703","title":"Procotol Review and Monitoring System","fiscal_year":2023,"amount_usd":203535,"organization":"CASE WESTERN RESERVE UNIVERSITY","source_url":"https://reporter.nih.gov/quickSearch/P30CA043703"},{"project":"P30CA043703","title":"Procotol Review and Monitoring System","fiscal_year":2022,"amount_usd":168692,"organization":"CASE WESTERN RESERVE UNIVERSITY","source_url":"https://reporter.nih.gov/quickSearch/P30CA043703"}],"source":"grants"},"congress":{"count":55,"years":{"first":2017,"last":2026},"societies":["AACR","ASCO","ASH"],"shown":3,"withheld":52,"rows":[{"title":"Abstract 1543: B-cell activating factor plays a critical role in CAR-T cell-associated cytokine release syndrome","society":"AACR","meeting":"AACR Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1158/1538-7445.am2026-1543","source_url":"https://doi.org/10.1158/1538-7445.am2026-1543","status":"verified"},{"title":"Avoidance of ATG improves outcomes in double-cord blood transplantation for hematological malignancies","society":"ASH","meeting":"ASH Annual Meeting","year":2025,"role":"presenting_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1182/blood-2025-2436","source_url":"https://doi.org/10.1182/blood-2025-2436","status":"verified"},{"title":"CD34 selected stem cell boost provides robust outcomes in patients with poor graft function","society":"ASH","meeting":"ASH Annual Meeting","year":2025,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1182/blood-2025-7790","source_url":"https://doi.org/10.1182/blood-2025-7790","status":"verified"}],"source":"congress"},"publications":{"total":11,"shown":5,"withheld":6,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Correction: Placental expanded mesenchymal-like cells (PLX-R18) for poor graft function after hematopoietic cell transplantation: A phase I study.","year":2025,"journal":"Bone marrow transplantation","types":["Published Erratum"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/39627347/","status":"verified"},{"title":"A multicenter study of posttransplantation low-dose inotuzumab ozogamicin to prevent relapse of acute lymphoblastic leukemia.","year":2024,"journal":"Blood advances","types":["Multicenter Study","Journal Article","Research Support, N.I.H., Extramural"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/38170741/","status":"verified"},{"title":"CML and the WHO: Why?","year":2024,"journal":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","types":["Journal Article","Research Support, Non-U.S. Gov't"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/38086008/","status":"verified"},{"title":"Placental expanded mesenchymal-like cells (PLX-R18) for poor graft function after hematopoietic cell transplantation: A phase I study.","year":2023,"journal":"Bone marrow transplantation","types":["Clinical Trial, Phase I","Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/37553467/","status":"verified"},{"title":"Impact of Visceral Obesity on Clinical Outcome and Quality of Life for Patients with Multiple Myeloma: A Secondary Data Analysis of STaMINA (BMT CTN 0702) Trial.","year":2023,"journal":"Research square","types":["Preprint","Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/37790413/","status":"verified"}],"most_cited":{"total":173,"shown":5,"withheld":168,"rows":[{"title":"Chronic Myeloid Leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology","year":2018,"cited_by_count":277,"type":"article","source_url":"https://doi.org/10.6004/jnccn.2018.0071"},{"title":"Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology","year":2020,"cited_by_count":262,"type":"article","source_url":"https://doi.org/10.6004/jnccn.2020.0047"},{"title":"Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology","year":2024,"cited_by_count":140,"type":"article","source_url":"https://doi.org/10.6004/jnccn.2024.0007"},{"title":"Human Mesenchymal Stromal Cells Attenuate Graft-Versus-Host Disease and Maintain Graft-Versus-Leukemia Activity Following Experimental Allogeneic Bone Marrow Transplantation","year":2014,"cited_by_count":89,"type":"article","source_url":"https://doi.org/10.1002/stem.1867"},{"title":"NCCN Guidelines Insights: Chronic Myeloid Leukemia, Version 1.2017","year":2016,"cited_by_count":83,"type":"article","source_url":"https://doi.org/10.6004/jnccn.2016.0162"}]},"source":"publications"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"Marcos J. G. De Lima","coauthored_works":93},{"name":"Ehsan Malek","coauthored_works":89,"profile_url":"https://www.findmykol.com/kol/ehsan-malek"},{"name":"Paolo Fabrizio Caimi","coauthored_works":84}],"source":"works"},"presence":{"mentions":{"total":2,"shown":2,"rows":[{"url":"https://case.edu/cancer/members/member-directory/leland-metheny","platform":"other","status":"verified"},{"url":"https://uhhospitals.org/find-a-doctor/metheny-leland-16006","platform":"other","status":"provisional"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":1,"shown":1,"rows":[{"value":"MD","source_url":"https://case.edu/cancer/members/member-directory/leland-metheny","status":"verified","collected_at":"2026-10-28"}]},"secondary_affiliations":{"total":2,"shown":2,"rows":[{"value":"Case Western Reserve University School of Medicine, Department of Medicine (Assistant Professor)","source_url":"https://case.edu/cancer/members/member-directory/leland-metheny","status":"verified","collected_at":"2026-10-28"},{"value":"Case Comprehensive Cancer Center, Immune Oncology Program (Member)","source_url":"https://case.edu/cancer/members/member-directory/leland-metheny","status":"verified","collected_at":"2026-10-28"}]}},"similar":[{"name":"Kenneth Anderson","slug":"kenneth-anderson","institution":"Dana-Farber Cancer Institute","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/kenneth-anderson","json_url":"https://www.findmykol.com/kol/kenneth-anderson/profile.json"},{"name":"Paul Richardson","slug":"paul-richardson","institution":"Dana-Farber Cancer Institute","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/paul-richardson","json_url":"https://www.findmykol.com/kol/paul-richardson/profile.json"},{"name":"S Rajkumar","slug":"s-rajkumar","institution":"Mayo Clinic","specialty":"Hematology","url":"https://www.findmykol.com/kol/s-rajkumar","json_url":"https://www.findmykol.com/kol/s-rajkumar/profile.json"},{"name":"Meletios Dimopoulos","slug":"meletios-dimopoulos","institution":"National and Kapodistrian University of Athens","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/meletios-dimopoulos","json_url":"https://www.findmykol.com/kol/meletios-dimopoulos/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":7,"payments":14,"funding":1,"congress":52,"publications":6,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-10-28"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-10-28"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 to 2025","collected_at":"2026-10-28"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year","collected_at":"2026-10-28"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-10-28"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-10-28"}},"methodology_url":"https://www.findmykol.com/about#methodology"}